Stay updated on CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Sign up to get notified when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.

Latest updates to the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page
- ChecktodayChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check7 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the study record content remains unchanged.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed. This reflects an update to the record’s documentation, signaling changes were made to the record since the prior version.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry v3.6.6 was added to the Study Record Versions and the previous revision v3.6.5 was removed, updating the record's version history.SummaryDifference0.1%

- Check70 days agoChange DetectedThe revision entry now shows Revision: v3.6.5 as the latest update, replacing the previous v3.6.4. This reflects a small update to the page metadata rather than a substantive change to the study record.SummaryDifference0.1%

- Check85 days agoChange DetectedA new revision entry v3.6.4 was added to the study’s history, while the previous revision v3.6.3 was removed. This reflects an update to the page’s version in the history log.SummaryDifference0.1%

Stay in the know with updates to CD19/CD20/CD22 Triple-targeted Cell Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD20/CD22 Triple-targeted Cell Clinical Trial page.